Novolin 70/30
NDC 0169-1837, Human Insulin, injection, suspension, from Novo Nordisk Pharmaceutical Industries, LP.
- Product NDC
- 0169-1837
- Status
- Listed
- Labeler
- Novo Nordisk Pharmaceutical Industries, LP
- Dosage form
- INJECTION, SUSPENSION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN OTC DRUG
- Marketing category
- BLA
- Application
- BLA019991
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0169-1837 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- INSULIN HUMAN100 [iU]/mL
Pharmacologic classes
Insulin [CS]; Insulin [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0169-1837-02 | 00169183702 | 1 VIAL in 1 CARTON (0169-1837-02) / 10 mL in 1 VIAL |
| 0169-1837-11 | 00169183711 | 1 VIAL in 1 CARTON (0169-1837-11) / 10 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
NADAC price for package 00169183711
GET /v1/drugs/nadac/00169183711
Use it
Look up 0169-1837 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0169-1837 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0169-1837. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.